Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/11744
Title: Developing a congenital hyperinsulinism prioritized research agenda: a patient-driven international collaborative research network
Authors: Pasquini, T. L. S.;Banerjee, I.;Christesen, H. T.;Conwell, L. S.;Dastamani, A.;De Leon, D. D.;Flanagan, S. E.;Gillis, D.;Kalish, J. M.;Lord, K.;Mesfin, M.;Schmitt, J.;Senniappan, S.;Stanley, C. A.;Thornton, P. S.;Zangen, D.;Raskin, J.
Issue Date: 2025
Source: Front Endocrinol (Lausanne), 2025 (16) p.1549310
Pages: 1549310
Journal Title: Front Endocrinol (Lausanne)
Abstract: INTRODUCTION: Congenital Hyperinsulinism (HI) is a rare disease that causes severe and recurrent hypoglycemia due to dysregulated insulin secretion. HI is the most frequent cause of severe, persistent hypoglycemia in newborns and children. Disease management is focused on preventing the neurological consequences associated with hypoglycemic brain injury; however, treatment is complex, often suboptimal, and places a large burden on families and individuals living with HI. Congenital Hyperinsulinism International (CHI) is an international patient organization that received a grant from the Chan Zuckerberg Initiative to establish the CHI Collaborative Research Network (CRN), a collaborative body to accelerate research for HI. ASSESSMENT PROCESS: Stakeholder groups relevant to HI, including individuals living with HI, families, researchers, clinicians, nurses, and industry partners, were identified to join the CRN and work together to create a prioritized research agenda (PRA) to systematically rank research priorities. CRN members worked across 7 workstream groups through a structured process to brainstorm gaps and corresponding solutions to formalize the HI PRA. ACTIONABLE RECOMMENDATIONS: A total of 362 gaps were identified across research, infrastructure, knowledge, and funding. All groups identified the need for an HI Natural History Study; therefore, this item was identified as a priority that would automatically be placed on the finalized list. Other top gaps identified in the PRA addressed preventing brain damage and the need to increase awareness and understanding related to the role of early and effective diagnosis in preventing brain damage. DISCUSSION: The formation of the CRN and the development of the PRA have already led to new collaborations, which are fundamental to progress. The PRA process allowed individuals to come to a consensus on the critical needs and to chart short- and long-term approaches to fill the gaps. CRN members continue to meet regularly in working groups focused on special projects to fill gaps identified as high priority by the PRA. Through this active and multidimensional alliance, the CRN is re-imagining the future for people living with HI by improving outcomes through more timely and accurate diagnosis, more effective and less burdensome treatments, more easily obtainable expert care, and better tools to manage HI.
DOI: 10.3389/fendo.2025.1549310
Appears in Sites:Children's Health Queensland Publications
Queensland Health Publications

Show full item record

Page view(s)

36
checked on Oct 8, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.